Cash-to-Doctors Data Reflect Rivalries
Physicians in two specialties receive more money from the pharmaceutical industry than their counterparts in other branches of medicine, according to new data analysis.
Big Pharma, Big Data
Patient groups are hailing a new era of transparency in drug development and clinical trials, but drug companies fear that the publication of so much trial data could damage their business models.
2 Clarke Drive Cranbury, NJ 08512